These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15145617)

  • 1. Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha.
    Feng J; Misu T; Fujihara K; Misawa N; Koyanagi Y; Shiga Y; Takeda A; Sato S; Takase S; Kohnosu T; Saito H; Itoyama Y
    J Neuroimmunol; 2004 Jun; 151(1-2):189-94. PubMed ID: 15145617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
    J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
    Oh U; Yamano Y; Mora CA; Ohayon J; Bagnato F; Butman JA; Dambrosia J; Leist TP; McFarland H; Jacobson S
    Ann Neurol; 2005 Apr; 57(4):526-34. PubMed ID: 15786444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran.
    Rafatpanah H; Rezaee A; Etemadi MM; Hosseini RF; Khorram B; Afsahr L; Taylor G; Mokhber N; Mahmoudi M; Abbaszadegan MR; Foroghipor M; Hashemi P; Amiri A; Tehrani M; Azarpazhooh A; Azarpazhooh MR
    J Neuroimmunol; 2012 Sep; 250(1-2):87-93. PubMed ID: 22727800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
    Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
    Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.
    Mori S; Mizoguchi A; Kawabata M; Fukunaga H; Usuku K; Maruyama I; Osame M
    Thorax; 2005 Feb; 60(2):138-43. PubMed ID: 15681503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
    Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
    J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
    Nascimento MC; Primo J; Bittencourt A; Siqueira I; de Fátima Oliveira M; Meyer R; Schriefer A; Santos SB; Carvalho EM
    Clin Exp Immunol; 2009 Jun; 156(3):455-62. PubMed ID: 19438598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.
    Rocha-Júnior MC; Haddad R; Cilião Alves DC; de Deus Wagatsuma VM; Mendes-Junior CT; Deghaide NH; Takayanagui OM; Covas DT; Donadi EA; Kashima S
    Tissue Antigens; 2012 Aug; 80(2):143-50. PubMed ID: 22587568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
    Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.